Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

25.33 0.43 −1.67%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
44.7×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100

Baxter International Inc. (BAX) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Baxter International Inc. (BAX) trades at a P/S ratio of 1.1×. Over the past ten years it has ranged from 0.7× (March 2026) to 4.2× (February 2020); the current reading is higher than 9% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.9× (37.64%)
FY2024 1.4× (26.31%)
FY2023 1.9× (25.82%)
FY2022 2.6× (27.90%)
FY2021 3.5× 1.40%
FY2020 3.5× (6.60%)
FY2019 3.7× 18.29%
FY2018 3.2× (8.10%)
FY2017 3.4× 44.34%
FY2016 2.4× 14.04%

Quarterly newest first

Period P/S ratio Change
Jun 2026 1.0× 25.74%
Mar 2026 0.8× (12.34%)
Dec 2025 0.9× (17.88%)
Sep 2025 1.1× (25.58%)
42 more quarters

Against its own ten years

Low 0.7× High 4.2×
Ten-year median 2.5×
Current reading's percentile 10

P/S ratio against peers

Company P/S ratio
BLCO Bausch + Lomb Corporation compare 1.1×
BAX Baxter International Inc. 1.1×
AVTR Avantor, Inc. compare 1.7×
SOLV Solventum Corporation compare 1.8×
ATR AptarGroup, Inc. compare 2.0×
ALGN Align Technology, Inc. compare 2.5×
COO The Cooper Companies, Inc. compare 2.6×
WST West Pharmaceutical Services, Inc. compare 8.1×
RGEN Repligen Corporation compare 12.6×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on BAX